Merus Labs International - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Merus Labs International M&A Summary

Merus Labs International has acquired 2 companies of its own.

Merus Labs International’s largest acquisition to date was in 2016, when it acquired UCB - Three Cardiovascular Products for $104M. Merus Labs International has acquired in 2 countries. The Company’s most targeted sectors include life science (50%) and medical products (50%).

Merus Labs International Ownership

Who owns Merus Labs International?

Merus Labs International is owned by Norgine B.V.. It was acquired on May 11, 2017.

Merus Labs International Business Overview

Where is Merus Labs International headquartered?

Merus Labs International is headquartered in Toronto, Ontario.

What is Merus Labs International’s revenue?

Merus Labs International disclosed revenue of 36M USD for 2015 and 23M USD for 2014.

How many employees does Merus Labs International have?

Merus Labs International has 10 employees.

What sector is Merus Labs International in?

Merus Labs International is a life science company.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 2
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 2

Merus Labs International, Inc.

100 Wellington Street West Suite 2110,
Toronto, Ontario M5K 1H1
Canada,
(416) 593-3725
www.meruslabs.com

Merus Labs International, Inc. is a specialty pharmaceutical company focused on acquiring and optimizing legacy and growth products. The Company leverages its expertise and scalable platform across Europe, Canada and select other markets to deliver value.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 2 - - - - - 2
vol $104M $104M
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
Sanofi - Surgestone, Provames, Tredemine and Speciafoldine Rights 2016-03-07 - Divestiture
, France
UCB - Three Cardiovascular Products 2016-02-01 104M EUR Divestiture
, Belgium
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (50%) - - -
Medical Products 1 (50%) 104M (100%) - -
Total 2 $104M - -

By Geo

State/Country Buy Value Sell Value
Belgium 1 104M - -
France 1 - - -
Domestic - - - -
Cross-border 2 (100%) 104M (100%) - -
Total 2 $104M - -

Deal Values

buy # Total
$100M to $1B 1 $104M
TOTAL $104M
Largest UCB - Three Cardiovascular Products
$104M (2016-02-01)

M&A Connections

Deals
Acquired from
Strategic(s)
100%
2 (100%)

 Subscribe to unlock this and 207,877
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.